Mass General Hospital

Generated Page Name: /cchi/ContentModules/TreatmentPrograms/Chelsea_Substance_Abuse_Initiative_1746.html

Active status: Inactive

Name of Treatment Program: Chelsea Substance Use Disorders (SUD) Initiative

Short description: The Chelsea Substance Use Disorders Initiative strengthens protective factors and decreases risk factors to prevent substance use and abuse for youth, adults and families through education, prevention and intervention strategies. The coalition also works to increase access to and resources for successful treatment and recovery from substance use disorders.

Image: /cchi/assets/Kayem Crew 11-8-14.jpg

Alt text: Kayem Park Clean up Crew

Call To Action 1:

Call To Action 2:

Call To Action 3:

Repeat calls to action::

Our approach:

The City of Chelsea, in partnership with Massachusetts General Hospital, has worked closely with a strong oversight committee to build a comprehensive community-based, environmental approach to reducing substance abuse and perception of safety. In Spring 2013,  a new Manager of Community-Based Substance Use Disorders Initiative was hired. He is responsible for providing overall leadership to the development and implementation of a comprehensive city-wide substance abuse plan where organizations, providers and residents have a role.

About this treatment:

2014 Outcomes

Related conditions intro:

Support & Wellness:

Related news & events intro:

Related multimedia intro:

Phone number: 617 887-3554

Condition:

Multidisciplinary Care Center:

Department:

Division:

Spotlights:

Contact: Dan Cortez - 1970

Tab1_label: Overview

Tab1_name: overview

Tab1_contentType: approach

Tab1_default:

Tab1_content:

Tab1_content_file:

tab2_label: About this Program

tab2_name: about

tab2_contentType: overview

tab2_default:

tab2_content:

tab2_content_file:

tab3_label: Conditions & Diseases

tab3_name: conditions

tab3_contentType: conditions

tab3_default:

tab3_content:

tab3_content_file:

tab4_label: Patient Education

tab4_name: patient-education

tab4_contentType: patient_education

tab4_default:

tab4_content:

tab4_content_file:

tab5_label: Clinical Trials

tab5_name: clinical-trials

tab5_contentType: clinical_trial

tab5_default:

tab5_content:

tab5_content_file:

tab6_label: News

tab6_name: news

tab6_contentType: news

tab6_default:

tab6_content:

tab6_content_file:

tab7_label: Video

tab7_name: video

tab7_contentType: multimedia

tab7_default:

tab7_content:

tab7_content_file:

tab8_label: Contact

tab8_name: contact

tab8_contentType: contact

tab8_default:

tab8_content:

tab8_content_file:

tab9_label:

tab9_name:

tab9_contentType:

tab9_default:

tab9_content:

tab9_content_file:

tab10_label:

tab10_name:

tab10_contentType:

tab10_default:

tab10_content:

tab10_content_file:

tab11_label:

tab11_name:

tab11_contentType:

tab11_default:

tab11_content:

tab11_content_file:

tab12_label:

tab12_name:

tab12_contentType:

tab12_default:

tab12_content:

tab12_content_file:

tab13_label:

tab13_name:

tab13_contentType:

tab13_default:

tab13_content:

tab13_content_file:

tab14_label:

tab14_name:

tab14_contentType:

tab14_default:

tab14_content:

tab14_content_file:

tab15_label:

tab15_name:

tab15_contentType:

tab15_default:

tab15_content:

tab15_content_file: